Skip to content
GLP-1 Support Supplement Prices logoGLP-1 Support

Berberine vs GLP-1 Medications: Is It "Nature’s Ozempic"?

Published 2026-09-22 · Updated 2026-09-22

By GLP-1 Support Supplement Prices editorial team

Editorial review checks sources, claim limits, and internal consistency. This is not medical review. Editorial policy

This site is for general information only and is not medical advice. Talk to your prescriber before starting any supplement.

As an Amazon Associate, this site earns from qualifying purchases.

Berberine gets called "nature's Ozempic." The nickname oversells it: no supplement replicates or replaces a GLP-1 medication, and berberine is no exception. We found no published human study showing that berberine raises GLP-1 in people. Its weight effect in pooled trials ranges from under 1 kg to about 2 kg, against about 15 to 21% for the medications.

Here is where the nickname comes from, what the trials show, and two questions worth asking before anyone buys: how berberine interacts with other medicines, and whether it is safe to take alongside a GLP-1 medication.

Where the "nature's Ozempic" idea comes from

The evidence behind the nickname comes from animals and cells, not people. We do not know who first coined the phrase. What matters is where the evidence stops.

  • In diabetic rats. Rats given berberine for 5 weeks had significantly higher GLP-1 levels in plasma and in the intestine (Lu et al. 2009).
  • In normal rats and in a cell line. Berberine stimulated GLP-1 release in normal rats and in a human intestinal cell line grown in a dish. In the cells, the effect rose with concentration (Yu et al. 2010).
  • No human participants in either. These are lab findings. They show what berberine did in rats and in a dish, not what a capsule does inside a person.

Does berberine raise GLP-1 in people?

We searched PubMed and ClinicalTrials.gov in September 2026. We found no published human study showing that berberine raises GLP-1 in people.

One registered study comes close, and it has no results. It enrolled 16 healthy men, measured GLP-1 and GIP during a glucose tolerance test, and compared berberine with placebo. It is listed as completed, with no results posted as of our September 2026 check (NCT05947370). Until those results are published, there is nothing to read.

There is also a ceiling on the idea itself. The body breaks down its own GLP-1 within about two minutes. Prescription GLP-1 medications are engineered to resist that breakdown and stay active far longer (Lee & Lee 2017). Even if berberine raised your own GLP-1, a signal that fades in minutes is not the same thing as a medication that does not.

Berberine vs GLP-1 medications on weight and blood sugar

On weight, the difference is one of scale. In STEP 1, semaglutide 2.4 mg produced an average weight change of minus 14.9% at 68 weeks, against minus 2.4% with placebo (Wilding et al. 2021). In SURMOUNT-1, tirzepatide reached up to minus 20.9% at 72 weeks, against minus 3.1% with placebo (Jastreboff et al. 2022). Berberine averaged minus 0.88 kg across 23 randomized trials (Elahi Vahed et al. 2026), and an earlier review of 12 small trials, mostly in people with metabolic disease, found minus 2.07 kg (Asbaghi et al. 2020).

On blood sugar, berberine has modest evidence. Pooling 37 trials in 3,048 people with type 2 diabetes, it lowered HbA1c by about 0.6 percentage points and fasting glucose by about 0.8 mmol/L, in studies of mostly moderate quality (Xie et al. 2022). The units, populations, and study designs differ across all of these trials, so the numbers show scale, not a head-to-head result. The full side-by-side is in our natural alternatives guide.

Swallowed berberine is poorly absorbed

Absorption is a real limit for berberine. One review of rat studies put its absolute oral bioavailability at 0.36 to 0.68% (Ai et al. 2021). Those are rats, not people. It is one more reason the lab findings do not transfer cleanly to a capsule.

Side effects were mostly stomach-related

Across 18 randomized trials with 1,788 participants, no serious adverse events were reported with berberine (Blais et al. 2023). Stomach side effects were the main caveat. They showed up in 12 of those trials and tended to be more frequent with berberine than with placebo, at 2 to 23% versus 2 to 15% (Blais et al. 2023). The authors note that berberine may occasionally cause constipation, diarrhea, or nausea.

Digestive side effects are also common with GLP-1 medications. Taking both at once could make it hard to tell which one is causing what. That is a reasonable caution, not a trial finding, because the combination has not been studied.

Berberine slows liver enzymes that clear other drugs

This is the part the nickname leaves out. In healthy men taking 300 mg of berberine three times a day for two weeks, activity fell for three liver enzymes that clear many common medicines: CYP2D6, CYP2C9, and CYP3A4 (Guo et al. 2012). Blood exposure to midazolam, a test drug cleared by CYP3A4, rose about 40%, and the authors concluded that drug interactions should be considered (Guo et al. 2012).

Goldenseal, a plant that contains berberine, lowered metformin levels by about 25% in healthy adults given the two together (NCCIH 2025). That result is about goldenseal extract, not purified berberine. The two findings differ, since one drug level went up and the other went down, but both show berberine-containing products can change how other medicines behave. Bring a complete medication list to your prescriber or pharmacist before adding berberine to anything.

Can you take berberine with Ozempic or Zepbound?

We found no published trial of berberine taken together with any GLP-1 medication in our September 2026 search. One trial is underway. It tests a multi-ingredient product that contains berberine, taken with and without semaglutide, in about 90 adults with prediabetes or type 2 diabetes (NCT07195994). It is industry-sponsored, and it was still recruiting as of September 2026, with no results.

So the honest answer is unknown. The combination has not been tested in people. That makes it a question for your prescriber or pharmacist, and an important one if you take diabetes medication, take other medicines cleared by the enzymes above, or are pregnant or breastfeeding.

Who should avoid it

The clearest warning in the sources we reviewed is about goldenseal. NIH's National Center for Complementary and Integrative Health advises that people who are pregnant or breastfeeding should not use goldenseal, and that it should not be given to infants, because the berberine in it can be harmful to newborns (NCCIH 2025). That guidance is written about goldenseal, not purified berberine supplements. If you are pregnant or breastfeeding, berberine belongs on the list of things to ask your prescriber about.

If you still want to try berberine

  • Ask the prescriber first. Talk to your prescriber or pharmacist before starting, especially if you take diabetes medication or any regular prescription.
  • Check the label math. Look for milligrams of berberine per serving and servings per container. Doses vary between products, and the label is the only place to find them.
  • A seal checks the label, not the benefit. Seals from USP, NSF, or ConsumerLab mean a product contains what the label says without harmful contaminants. They do not show whether it works (NIH ODS 2023).
  • Skip listings that borrow drug names. A listing that uses a prescription drug name as a claim is a red flag. Nothing in a bottle replicates or replaces a GLP-1 medication.

Current prices per serving

Current lowest prices per serving from our tracked catalog:

These are supplements tracked in our GLP-1 support category, not substitutes for the medication. A listing is not a recommendation. The full list is on the GLP-1 support category page.

When to talk to your prescriber

Several points on this page are prescriber conversations, not checkout decisions. Bring the question and a full medication list.

  • You take diabetes medication. Berberine affects blood sugar markers, and goldenseal lowered metformin levels in healthy adults in the study above. Ask before adding anything.
  • You take other regular medicines. The liver enzyme effect above covers many common drugs, not just one.
  • You are pregnant or breastfeeding. The goldenseal guidance above is the reason to ask rather than assume.
  • You want to combine it with a GLP-1 medication. The combination has not been tested in people.

This page is general information, not medical advice. Your prescriber knows your situation. We do not.

Related reading

Quick answers

Is berberine as effective as Ozempic? No. Ozempic is one brand name for semaglutide. In the trials cited above, semaglutide produced an average weight change of minus 14.9% at 68 weeks, and tirzepatide reached up to minus 20.9% at 72 weeks. Berberine averaged minus 0.88 kg across 23 randomized trials, in studies with noted problems in blinding, randomization, and purity reporting. The units and designs differ, so this is a comparison of scale, not a head-to-head result. And no supplement replicates or replaces a GLP-1 medication.

Does berberine increase GLP-1? In people, we found no published human study when we searched PubMed and ClinicalTrials.gov in September 2026. In rats and in cells in a dish, berberine did raise GLP-1, but those are lab findings. One 16-person study in healthy men is registered as completed, with no results posted. Also worth knowing: the body breaks down its own GLP-1 within about two minutes, while prescription GLP-1 medications are engineered to stay active far longer.

Can I take berberine with a GLP-1 medication? The honest answer is unknown. We found no published trial of the combination in our September 2026 search. One industry-sponsored trial of a multi-ingredient product containing berberine, tested with and without semaglutide, was still recruiting with no results. Ask your prescriber or pharmacist. Berberine also slows liver enzymes that clear many common medicines, which matters beyond the GLP-1 question alone.

Is berberine safe? Across 18 randomized trials with 1,788 participants, no serious adverse events were reported. Stomach side effects, such as constipation, diarrhea, or nausea, tended to be more frequent with berberine than with placebo in the trials that tracked them. Two cautions sit outside those trials: berberine slows liver enzymes that clear many common medicines, and NIH guidance for goldenseal, a plant that contains berberine, says people who are pregnant or breastfeeding should not use it. Both are reasons to talk to your prescriber or pharmacist first.

Check with your care team first if:

  • Pregnant, trying to conceive, or breastfeeding. Ask your prescriber before starting any new supplement.
  • Type 1 diabetes, or taking insulin or a sulfonylurea. Products sold for blood sugar support, such as berberine or chromium, may add to the effect of those medicines. Ask before combining them.
  • A history of an eating disorder. Appetite and weight products can make recovery harder. Talk with your care team first.
  • Kidney disease. Electrolyte, protein, and creatine products change what your kidneys have to handle. Ask about your limits.
  • Other prescriptions. Fiber can slow how some medicines are absorbed. Ask your pharmacist how to space doses.

Sources

Each source below was read before being cited. Where a study was not conducted in people taking GLP-1 medications, that limit is stated with the reference.

  1. 1. Ai X, Yu P, Peng L, Luo L, Liu J, Li S, Lai X, Luan F, Meng X. Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases. Frontiers in Pharmacology, 12:762654, 2021.The bioavailability figures come from studies in rats, not people.
  2. 2. Asbaghi O, Ghanbari N, Shekari M, Reiner Z, Amirani E, et al.. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN, 38:43-49, 2020.Only 12 small trials, mostly in people with metabolic disease.
  3. 3. Blais JE, Huang X, Zhao JV. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Drugs, 83(5):403-427, 2023.Side effects were described, not pooled, across short trials run mostly in mainland China and Hong Kong.
  4. 4. Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al.. The effect of berberine on obesity indices: a systematic review and meta-analysis. International Journal of Obesity, 50(1):53-73, 2026.The pooled trials had problems with blinding, randomization, and reporting of berberine purity and dose.
  5. 5. Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology, 68(2):213-217, 2012.A small study in healthy men using test drugs, so the size of real-world interactions is uncertain.
  6. 6. Jastreboff AM, Aronne LJ, Ahmad NN, et al.; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3):205-216, 2022.Manufacturer-funded trial that excluded people with diabetes.
  7. 7. Lee S, Lee DY. Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes. Annals of Pediatric Endocrinology & Metabolism 22(1):15-26, 2017.
  8. 8. Lu SS, Yu YL, Zhu HJ, Liu XD, Liu L, Liu YW, Wang P, Xie L, Wang GJ. Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. Journal of Endocrinology, 200(2):159-165, 2009.A study in diabetic rats. It shows a possible mechanism, not an effect in people.
  9. 9. National Center for Complementary and Integrative Health. Goldenseal. National Center for Complementary and Integrative Health (NIH), 2025.About goldenseal, a plant that contains berberine, not about purified berberine supplements.
  10. 10. Beijing Tongren Hospital (sponsor). The Effect of Berberine on the Secretion of Incretin in Normal Man. ClinicalTrials.gov registry record, 2023.A registry entry for a 16-person study marked completed, with no results posted when checked.
  11. 11. QuickSilver Scientific (sponsor). A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes. ClinicalTrials.gov registry record, 2025.Still recruiting when checked. It tests a multi-ingredient product that contains berberine, not berberine alone.
  12. 12. NIH Office of Dietary Supplements. Dietary Supplements: What You Need to Know. National Institutes of Health, Office of Dietary Supplements, 2023.A testing seal describes product quality, not benefit. ODS endorses no particular tester.
  13. 13. Wilding JPH, Batterham RL, Calanna S, et al.; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11):989-1002, 2021.Manufacturer-funded trial in adults without diabetes. Both groups also received a lifestyle intervention.
  14. 14. Xie W, Su F, Wang G, et al.. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Frontiers in Pharmacology 13:1015045, 2022.Pooled 37 trials and 3,048 people with type 2 diabetes. The authors rate most included studies as moderate quality, mainly for poor reporting of allocation concealment.
  15. 15. Yu Y, Liu L, Wang X, Liu X, Liu X, Xie L, Wang G. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochemical Pharmacology, 79(7):1000-1006, 2010.Rats and a human intestinal cell line in a dish. No human participants.
Berberine vs GLP-1 Medications: Is It "Nature’s Ozempic"?